Lacosamide Strides

Lacosamide, the active ingredient in Lacosamide Strides, is an Anticonvulsant presented as an oral formulation for oral use. It is employed to treat partial‑onset seizures and is used as adjunctive therapy in patients with epilepsy who require additional seizure control.

GNH USA supplies Lacosamide Strides as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an antiepileptic drug that targets focal seizure activity. It is indicated for the following conditions: - Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy. - Adjunctive therapy for epilepsy: used together with other antiepileptic drugs to improve overall seizure control. - Focal epilepsy: provides additional seizure reduction when monotherapy is insufficient.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: feeling of stomach upset or urge to vomit. - Fatigue: persistent tiredness or lack of energy. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm requiring medical attention. - Suicidal ideation: thoughts of self‑harm that need immediate evaluation. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hypersensitivity: including rash, swelling, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes indicating possible liver injury.

Before initiating therapy, several safety considerations should be observed. - Monitor cardiac function: obtain baseline ECG and watch for PR‑interval changes. - Assess renal function: dose may need adjustment in patients with renal impairment. - Avoid abrupt discontinuation: taper the dose under medical supervision to prevent seizure worsening. - Use caution in hepatic disease: monitor liver enzymes periodically. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with several medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Concomitant carbamazepine: may lower lacosamide plasma concentrations. - CYP2C19 inhibitors (e.g., fluconazole): can increase lacosamide levels and toxicity risk. - Other sodium‑channel blockers: heightened risk of central nervous system depression.

Moderate Interactions (Monitor Closely): - Alcohol: may intensify dizziness and sedation. - Co‑administration with other antiepileptics (e.g., valproate): monitor therapeutic efficacy. - Warfarin: observe INR values as lacosamide may affect anticoagulation control.